Company Filing History:
2 out of 21 
Years Active: 2024-2025
Title: The Innovative Contributions of Katie Grace Cooper in Pharmaceutical Chemistry
Introduction
Katie Grace Cooper, an inventive pharmaceutical chemist based in Cambridge, GB, has made significant strides in the development of innovative compounds with potential applications in cancer treatment. With a commendable portfolio of 2 patents, her work epitomizes the intersection of creativity and science in the pharmaceutical field.
Latest Patents
Her latest patent, detailed in International Patent Application WO2011154737, focuses on a pharmaceutical process for the preparation of 4-{4-[(3R)-3-methylmorpholin-4-yl]-6-[1-((R)-S-methylsulfonimidoyl) cyclopropyl]pyrimidin-2-yl}-1H-pyrrolo[2,3-b]pyridine and its intermediates. This patent pertains specifically to the large-scale manufacture of vital pharmaceutical compounds, including the morpholine pyrimidines noted for their utility in cancer treatments. Furthermore, the compound of Formula (I) outlined in the patent showcases a well-defined synthetic route which is crucial for the advancement of therapeutic agents.
Additionally, Katie is credited with another impactful patent that improves processes for the manufacture of 4-{8-amino-3-[(2S)-1-(but-2-ynoyl)-pyrrolidin-2-yl]imidazo[1,5-a]-pyrazin-1-yl}-N-(pyridin-2-yl)-benzamide. This patent also emphasizes the development of large-scale processes and intermediates, further solidifying her contributions to the pharmaceutical manufacturing landscape.
Career Highlights
Throughout her career, Katie has been associated with Acerta Pharma B.V., where her innovative research has played a pivotal role in advancing pharmaceutical methodologies. Her expertise and focus on scalable processes demonstrate her commitment to enhancing drug development strategies in the industry.
Collaborations
Katie collaborates with talented peers including Lucinda Victoria Jackson and Paul Allen Bethel. Their combined efforts contribute significantly to the success of Acerta Pharma B.V. and reflect a strong team dynamic in the pursuit of groundbreaking pharmaceutical advancements.
Conclusion
In summary, Katie Grace Cooper stands out as a notable inventor in the pharmaceutical sector, with her patents emphasizing the importance of innovative processes in drug development. Her work not only represents her personal achievements but also highlights the collaborative spirit within the scientific community aimed at enhancing human health through effective treatments.